News
Roche to streamline research and development activities
Roche site in Nutley to be closed - respective R&D activities to be consolidated in Switzerland and Germany. The planned site consolidation and the streamlining of research activities within Roche's Pharma Research and Early Development unit to support...
News
Metformin may lower cancer risk in people with Type 2 diabetes
A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results have been presented at The Endocrine Society's 94th Annual Meeting in Houston. ...
News
People with HER2-positive metastatic breast cancer lived longer with Roche’s Perjeta
Roche announced that people with HER-2 positive metastatic breast cancer (mBC) lived significantly longer (overall survival) when treated with the combination of PerjetaTM (pertuzumab), Herceptin® (trastuzumab) and docetaxel chemotherapy, compared to Herceptin and docetaxel chemotherapy alone in the...
News
Common blood pressure drug linked to severe GI problems
Mayo Clinic researchers have discovered an association between a commonly prescribed blood pressure drug, Olmesartan, and severe gastrointestinal issues such as nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities - symptoms common among those who have celiac disease....
News
Bristol-Myers Squibb and Emory University announce partnership
Bristol-Myers Squibb Company and Emory University announced the formation of a strategic partnership to conduct clinical trials involving Bristol-Myers Squibb's investigational compounds. Under the newly established Master Clinical Trial Agreement, investigators from Emory University...
News
Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes
Sanofi and the Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical School, announced a new collaboration to promote the development of new medicines for the treatment of diabetes and related disorders. The collaboration was unveiled...
News
Takeda’s exclusive distribution of Pfizer products in Japan
Takeda Pharmaceutical Company Limited ("Takeda") and Pfizer Japan Inc. ("Pfizer") announced that they have concluded an agreement that, as of December 31, 2012, Takeda will cease distribution of 13 out of the 15 Pfizer products that it previously...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read